Genistein inhibits proliferation and functions of hypertrophic scar fibroblasts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18976864.
- Also identified by DOI 10.1016/j.burns.2008.03.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypertrophic scarring is abnormal proliferation of dermal fibroblasts and excessive deposition of extracellular matrix. To date, despite many studies, treatments have not been satisfactory. Genistein, a potent, specific inhibitor of tyrosine protein kinases (TPKs), has been proved to inhibit many kinds of tumour and some fibrotic diseases. The purpose of this study was to investigate the effects of genistein on the proliferation and functions of hypertrophic scar fibroblasts (HSFBs) and the mechanism by which genistein inhibits TPK signal transduction. The first effect was observed by methyl-thiazol-diphenyl-tetrazolium assay and the second by [gamma-(32)p] adenosine triphosphate incorporation assay. The results demonstrated that genistein inhibits the proliferation and function of HSFBs and changes the TPK signal transduction pathway, which can provide an experimental basis for treating HS with genistein.
Medical subject headings
- Cicatrix, Hypertrophic
- Fibroblasts
- Genistein
- Protein Kinase Inhibitors
- Protein-Tyrosine Kinases
- Skin